Antibody responses to Borrelia burgdorferi in patients with antibiotic‐refractory, antibiotic‐responsive, or non–antibiotic‐treated lyme arthritis
- 29 November 2007
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 56 (12) , 4216-4225
- https://doi.org/10.1002/art.23135
Abstract
Objective To compare the pattern of antibody responses to Borrelia burgdorferi in patients with antibiotic‐refractory, antibiotic‐responsive, or non–antibiotic‐treated Lyme arthritis as an indirect measure of spirochetal persistence or eradication. Methods At least 3 serial serum samples from 41 patients with antibiotic‐refractory arthritis and 23 patients with antibiotic‐responsive arthritis, and samples from 10 non–antibiotic‐treated, historical control patients were tested for IgG reactivity with B burgdorferi sonicate and 4 differentially expressed outer surface lipoproteins of the spirochete, by enzyme‐linked immunosorbent assay. Results Among non–antibiotic‐treated patients, antibody titers to B burgdorferi antigens remained high throughout a 2–5‐year period of arthritis. In contrast, in patients with antibiotic‐responsive arthritis, in whom joint swelling usually resolved during a 1‐month course of oral antibiotic therapy, the median antibody titers to most of the spirochetal antigens remained steady or decreased during the first 1–3 months after starting antibiotic therapy. In patients with antibiotic‐refractory arthritis, who had persistent joint swelling for a median duration of 10 months despite 2–3 months of oral or intravenous antibiotics, the median titers to most antigens increased slightly during the first 1–3 months. However, by 4–6 months after starting antibiotic therapy, reactivity with all antigens declined similarly in both antibiotic‐treated groups. Conclusion Whereas the antibody titers to B burgdorferi remained high in non–antibiotic‐treated patients, the titers declined similarly 4–6 months after starting therapy in patients with antibiotic‐responsive or antibiotic‐refractory arthritis, suggesting that synovial inflammation persisted in patients with antibiotic‐refractory arthritis after the period of infection.Keywords
This publication has 40 references indexed in Scilit:
- The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2006
- Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind aBorrelia burgdorferipeptideThe Journal of Experimental Medicine, 2006
- Human Lyme Arthritis and the Immunoglobulin G Antibody Response to the 37-Kilodalton Arthritis-Related Protein of Borrelia burgdorferiInfection and Immunity, 2005
- Elucidation of Lyme arthritisNature Reviews Immunology, 2004
- Recombinant or Peptide Antigens in the Serology of Lyme Arthritis in ChildrenThe Journal of Infectious Diseases, 2003
- Serodiagnosis of Lyme Disease by Kinetic Enzyme‐Linked Immunosorbent Assay Using Recombinant VlsE1 or Peptide Antigens ofBorrelia burgdorferiCompared with 2‐Tiered Testing Using Whole‐Cell LysatesThe Journal of Infectious Diseases, 2003
- Persistence of the Antibody Response to the VlsE Sixth Invariant Region (IR6) Peptide ofBorrelia burgdorferiafter Successful Antibiotic Treatment of Lyme DiseaseThe Journal of Infectious Diseases, 2003
- Lyme DiseaseNew England Journal of Medicine, 2001
- Lyme Arthritis Resolution with Antiserum to a 37-KilodaltonBorrelia burgdorferiProteinInfection and Immunity, 2000
- Antibody Response in Lyme Disease: Evaluation of Diagnostic TestsThe Journal of Infectious Diseases, 1984